C-reactive protein and myocardial infarction during percutaneous coronary intervention

Journal of Internal Medicine

Volumn 255, Issue 1, 2004, Pages 33-39

  Saleh, N ^a   Svane, B ^a   Velander, M ^a   Nilsson, T ^a   Hansson, L O ^a   Tornvall, P ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

C reactive protein; Myocardial infarction; Percutaneous coronary intervention; Procedure time; Stent implantation; Troponin T

Indexed keywords

C REACTIVE PROTEIN; TROPONIN T;

ADULT; AGED; ARTICLE; CORONARY STENT; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; STABLE ANGINA PECTORIS; UNSTABLE ANGINA PECTORIS;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; C-REACTIVE PROTEIN; FEMALE; HUMANS; INTRAOPERATIVE COMPLICATIONS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; PROSPECTIVE STUDIES; RISK FACTORS; STENTS; TIME FACTORS; TROPONIN T;

EID: 1642540206     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0954-6820.2003.01255.x     Document Type: Article

References (40)

1. Abdelmaguid A, Topol E, Whitlow P et al. Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions. Circulation 1996; 94: 1528-1536.
2. Stone G, Mehran R, Dangas G et al. Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention. Circulation 2001; 104: 642-647.
3. Rottbauer W, Greten T, Müller-Bardoff M et al. Troponin T: a diagnostic marker for myocardial infarction and minor cardiac damage. Eur Heart 1997; 17: f3-f8.
4. Hamm C, Ravkilde J, Gerhardt W et al. The prognostic value of serum troponin T in unstable angina. N Engl J Med 1992; 327: 146-150.
5. Lindahl B, Venge P, Wallentin L et al. Relation between troponin T and the risk of subsequent cardiac events in unstable artery disease. Circulation 1996; 93: 1651-1657.
6. Warren J, Newby K, Christenson R et al. Prognostic significance of elevated troponin I after percutaneous coronary intervention. J Am Coll Cardiol 2002; 39: 1738-1744.
7. Saadeddin S, Habbab M, Sobki S et al. Detection of minor myocardial injury after successful percutaneous transluminal coronary angioplasty with or without stenting. Med Sci Monit 2000; 6: 708-712.
8. Ricchiuti V, Shear W, Henry T et al. Monitoring plasma cardiac troponin I for the detection of myocardial injury after percutaneous transluminal coronary angioplasty. Clinica Chimica Acta 2000; 302: 161-170.
9. La Vecchia L, Bedgoni F, Finocchi G et al. Troponin T, troponin I and creatine kinase-MB mass after coronary stenting. Coronary Artery Dis 1996; 7: 535-540.
10. Tardiff B, Califf R, Tchong J et al. Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. IMPACT-II Investigators. J Am Coll Cardiol 1999; 33: 88-96.
11. Nageh T, Harris B, Sherwood R et al. The prognostic value of cardiac troponin I following coronary artery intervention. Eur Heart J 2000; 21: 501.
12. Akkerhuis K, Alexander J, Tardiff B et al. Minor myocardial damage and prognosis. Circulation 2002; 105: 554-556.
13. Simoons M, Van den Brand M, Lincoff M et al. Minimal myocardial damage during coronary Intervention is associated with impaired outcome. Eur Heart J 1999; 20: 1112-1119.
14. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-126.
15. Libby P, Ridker P. Novel inflammatory markers of coronary risk. Theory versus practice. Circulation 1999; 100: 1148-1150.
16. Buffon A, Liuzzo G, Biasuuci L et al. Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty. J Am Coll Cardiol 1999; 34: 1512-1521.
17. Chew D, Bhatt D, Robbins M et al. Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention. Circulation 2001; 104: 992-997.
18. Mueller C, Buettner H, Hodgsen J et al. Inflammation and long-term mortality after non-ST elevation acute coronary syndrome treated with a very early invasive strategy in 1042 consecutive patients. Circulation 2002; 105: 1412-1415.
19. Versaci F, Gaspardone A, Tomai F et al. Predictive value of C-reactive protein in patients with unstable angina pectoris undergoing coronary artery stent implantation. Am J Cardiol 2000; 85: 92-94.
20. Gottsauner-Wolf M, Zasmeta G, Hornykewycz S et al. Plasma levels of C-reactive protein after coronary stent implantation. Eur Heart J 2000; 21: 1152-1158.
21. Walter D, Fichtlschere S, Britten M et al. Statin therapy. Inflammation and recurrent coronary events in patients following coronary stent implantation. J Am Coll Cardiol 2001; 38: 2006-2012.
22. Chan A, Bhatt D, Chew D et al. Early and sustained survival benefit associated with statin therapy at the time of percutaneous coronary intervention. Circulation 2002; 105: 691-696.
23. Albert M, Danielson E, Rifai N et al. Effect of statin therapy on C-reactive protein levels. JAMA 2001; 286: 64-70.
24. Saadeddin S, Habbab M, Sobki S et al. Association of systemic inflammatory state with troponin I elevation after elective uncomplicated percutaneous coronary intervention. Am J Cardiol 2002; 89: 981-983.
25. Talasz H, Genser N, Mair J et al. Side-branch occlusion during percutaneous transluminal coronary angioplasty. Lancet 192; 339: 1380-1382.
26. Oh J, Shub C, Ilstrup D et al. Creatine kinase release after successful percutaneous transluminal coronary angioplasty. Am Heart J 1980; 109: 1225-1231.
27. Bertinchant J, Polge A, Ledermann B et al. Relation of minor cardiac troponin I elevation to late cardiac events after uncomplicated elective successful percutaneous transluminal coronary angioplasty for angina pectoris. Am J Cardiol 1999; 84: 51-57.
28. Johansen O, Brekke M, Strømme J et al. Myocardial damage during percutaneous transluminal coronary angioplasty as evidenced by troponin T measurements. Eur Heart J 1998; 19: 112-117.
29. Garbaz E, Iung B, Lefevre G et al. Frequency and prognostic value of cardiac troponin I elevation after coronary stenting. Am J Cardiol 1999; 84: 515-518.
30. Ellis S, Vandormal M, Cowley M et al. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group. Circulation 1990; 82: 1193-1202.
31. Benamer H, Steg P, Benessiano J et al. Elevated cardiac troponin I predicts a high-risk angiographic anatomy of the culprit lesion in unstable angina. Am Heart J 1999; 137: 815-820.
32. Tan K, Sulke N, Taub N et al. Clinical and lesion morphologic determinants of coronary angioplasty success and complications: current experience. J Am Coll Cardiol 1995; 25: 855-865.
33. Ellis S, Guetta V, Miller D et al. Relation between lesion characteristics and risk with percutaneous intervention in the stent and glycoprotein IIb/IIIa era. Circulation 1999; 100: 1971-1976.
34. The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000; 36: 959-969.
35. Braunwald E. Unstable angina: a classification. Circulation 1989; 80: 410-414.
36. Bunch T, Muhlestein J, Anderson J et al. Effects of statins on six-month survival and clinical restenosis frequency after coronary stent deployment. Am J Cardiol 2002; 90: 299-302.
37. Sharma S, Kini A, Marmur J et al. Cardioprotective effect of prior β-blocker therapy in reducing creatine kinase-MB elevation after coronary intervention: benefit is extended to improvement in intermediate-term survival. Circulation 2002; 102: 166-172.
38. Ellis S, Brener S, Lincoff M et al. β -Blockers before percutaneous coronary intervention do not attenuate postprocedural creatine kinase isoenzyme rise. Circulation 2001; 104: 2685-2688.
39. Bugiardini R, Pozzati A, Borghi A et al. Angiographic morphology in unstable angina and its relation to transient myocardial ischemia and hospital outcome. Am J Cardiol 1991; 67: 460-464.
40. Kastrati A, Schömig A, Elezi S et al. Prognostic value of the modified American College of Cardiology/American Heart Association stenosis morphology classification for long-term angiographic and clinical outcome after coronary stent placement. Circulation 1999; 100: 1285-1290.